Summary of all studies containing PUBCHEM ID 5283568
| Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
|---|---|---|---|---|---|
| PR000004 | ST000005 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Animal | Mus musculus | C24:1 Cer [Data] |
| PR000219 | ST000828 | Metabolic analysis of Parp1 ko/wt Saline & Bleo Mouse Lung Fiboblasts and Human IPF & Normal Lung Fiboblasts 3 | HUMAN | Homo sapiens | C24:1 CER [Data] |
| PR000589 | ST000827 | Metabolic analysis of Normal Mouse Lung Fiboblasts with/without TGFbeta treatment | MOUSE | Mus musculus | C24:1 CER [Data] |
| PR001935 | ST003114 | Lipidomics analyses in model membranes, isolated mitochondria and cellular systems to study how the local lipid environment affects BAX and BAK function during apoptosis. | Cultured cells | Homo sapiens | Cer 18:1;O2/24:1 [Data] |
| PR000121 | ST000136 | NIST lipidomics intralaboratory study | Human | Homo sapiens | Cer 24:1 [Data] |
| PR001451 | ST002269 | Targeted plasma metabolomics in pediatric NAFLD patients | Human | Homo sapiens | Cer(42:2) [Data] |
| PR001890 | ST003038 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Mammal | Mus musculus | Cer 42:2;2O|Cer 18:2;2O/24:0 (648.63092@9.414) [Data] |
| PR001162 | ST001840 | Metabolomics of lung microdissections reveals region- and sex-specific metabolic effects of acute naphthalene exposure in mice (part I) | Mammal | Mus musculus | Ceramide 42:2 [Data] |
| PR000348 | ST000450 | Metabolic features of chronic fatigue syndrome | Human | Homo sapiens | Ceramide(d18:1/24:1) [Data] |
| PR000357 | ST000465 | Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response | Human renal cancer cells | Homo sapiens | Ceramide(d18:1/24:1) [Data] |
| PR000055 | ST000077 | Metabolite changes associated with methionine stress sensitivity of cancer (CSH QTOF MS analysis) | Human cells | Homo sapiens | Ceramide (d42:2) [Data] |
| PR000058 | ST000081 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of subcutaneous and visceral adipose tissue samples | Human | Homo sapiens | Ceramide (d42:2) [Data] |
| PR000058 | ST000082 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of serum samples | Human | Homo sapiens | Ceramide (d42:2) [Data] |
| PR000079 | ST000089 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis | Human cells | Homo sapiens | Ceramide (d42:2) [Data] |
| PR000260 | ST000321 | Effects of LGG on current drinkers gut metabolism | Animal | Mus musculus | Ceramide (d42:2) [Data] |
| PR000261 | ST000323 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 2:Uterine flush) | Animal | Bos taurus | Ceramide (d42:2) [Data] |
| PR000261 | ST000324 | Progesterone level effects on primary metabolites in uterus, blood, and ovaries (Part 3:Ovaries) | Animal | Bos taurus | Ceramide (d42:2) [Data] |
| PR000263 | ST000328 | Primary metabolites at different points along dog gastrointestinal tract (CSH chromatography) | Animal | Canis lupus familiaris | Ceramide (d42:2) [Data] |
| PR000264 | ST000329 | Minimal change disease and focal segmental sclerosis in urine | Human | Homo sapiens | Ceramide (d42:2) [Data] |
| PR000265 | ST000330 | Effects of Zinc on GI tract metabolites (Part 1: Esophagus) | Animal | Mus musculus | Ceramide (d42:2) [Data] |
| PR000265 | ST000331 | Effects of Zinc on GI tract metabolites (Part 2: Prostate) | Animal | Mus musculus | Ceramide (d42:2) [Data] |
| PR000266 | ST000332 | Effects of Giardia intestinalis on mice GI tract | Animal | Mus musculus | Ceramide (d42:2) [Data] |
| PR000271 | ST000339 | Metabolites in peritoneal macrophages and bone marrow derived macrophages | Animal | Mus musculus | Ceramide (d42:2) [Data] |
| PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | Ceramide d42:2; [Data] |
| PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | Ceramide d42:2; [Data] |
| PR001748 | ST002817 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Mammal | Mus musculus | Ceramide(d42:2) A [Data] |
| PR001285 | ST002023 | A targeted metabolomics study for assessing rodent thyroid toxicity | Mammal | Rattus norvegicus | Ceramides__Cer(d18:1/24:1) [Data] |
| PR000219 | ST000295 | Metabolic analysis of Human and Mouse Lung Fiboblasts | Human/animal | Mus musculus;Homo sapiens | Cer C24:1 [Data] |
| PR000413 | ST000562 | Brown vs White adipose tissue | Animal | Mus musculus | Cer C24:1 [Data] |
| PR001455 | ST002274 | 1-deoxysphingolipid synthesis compromises anchorage-independent growth and plasma membrane endocytosis in cancer cells | Cultured cells | Homo sapiens | Cer d18:1/24:1 [Data] |
| PR000004 | ST000004 | Lipidomics studies on NIDDK / NIST human plasma samples | Human | Homo sapiens | Cer(d18:1/24:1) [Data] |
| PR000213 | ST000269 | Diacylglyceride and Ceramide analysis in TFD mice | Animal | Mus musculus | Cer(d18:1/24:1) [Data] |
| PR001737 | ST002787 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Human | Homo sapiens | Cer(d18:1/24:1) [Data] |
| PR001883 | ST003222 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Mammal | Mus musculus | Cer(d18:1/24:1) [Data] |
| PR000471 | ST000668 | Diet manipulation on the lipidome | Human | Homo sapiens | Cer(d42:2)[M+H]+ [Data] |
| PR000473 | ST000670 | Exposure to high fat diets and bisphenol | Mouse | Mus musculus | Cer(d42:2)[M+H]+ [Data] |
| PR000673 | ST000992 | Metabolomic Markers of Dietary Patterns in the Costa Rica Study | HUMAN | Homo sapiens | Cer(d42:2)[M+H]+ [Data] |
| PR000471 | ST000668 | Diet manipulation on the lipidome | Human | Homo sapiens | Cer(d42:2)[M+Na]+ [Data] |
| PR000473 | ST000670 | Exposure to high fat diets and bisphenol | Mouse | Mus musculus | Cer(d42:2)[M+Na]+ [Data] |
| PR000673 | ST000992 | Metabolomic Markers of Dietary Patterns in the Costa Rica Study | HUMAN | Homo sapiens | Cer(d42:2)[M+Na]+ [Data] |
| PR000480 | ST000679 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part II | Human | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.43 [Data] |
| PR000485 | ST000686 | Lipodomics and Gestational bisphenol A (BPA) exposure | Animal | Ovis aries | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.45 [Data] |
| PR000487 | ST000688 | Biomarkers for different types of Multiple Scelerosis (MS) (BMS vs SPMS lipidomics) | Human | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.45 [Data] |
| PR000480 | ST000678 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) | Human | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.46 [Data] |
| PR000484 | ST000685 | Lipidomics analysis for human liver cell lines | Human | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.46 [Data] |
| PR000537 | ST000744 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Human | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.46 [Data] |
| PR000543 | ST000753 | Comparison of the metabolome and lipidome of wild type and mdx/mTR mice | Mouse | Mus musculus | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.46 [Data] |
| PR000583 | ST000818 | Integrated nutrigenomic and metabolomic analysis of Africans with variable diet | HUMAN | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.46 [Data] |
| PR000482 | ST000683 | Untargeted Lipidomics for hepatic lipid profile wild type versus knockout | Mouse | Mus musculus | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.47 [Data] |
| PR000536 | ST000743 | Metabolomics of bariatric weight loss | Human | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.47 [Data] |
| PR000510 | ST000823 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | HUMAN | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.50 [Data] |
| PR000479 | ST000677 | Nonalcoholic steatohepatitis (NASH) changes with S.Q. Leptin administrations | Human | Homo sapiens | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.52 [Data] |
| PR000478 | ST000676 | Effect of high fat diet and streptozotocin treatment on neuropathy | Mouse | Mus musculus | N-(15Z-tetracosenoyl)-sphing-4-enine; [M-H]-@8.53 [Data] |
| PR001139 | ST001795 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mammal | Mus musculus | N-(2-hydroxyoctadecanoyl)-phytosphingosine [Data] |
| PR001748 | ST002815 | Investigation of metabolism in hypertrophic cardiomyopathy - HILIC | Mammal | Mus musculus | N-Tetracosenoyl-4-sphingenine [Data] |
